Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydralazine + valproate pilot study in recent-onset narcolepsy type 1
NL-OMON54746Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydralazine and valproic acid in narcolepsy type 1 (NT1), sponsored by Leiden University Medical Center. Primary endpoint: Weekly cataplexy rate. Started Jul 2021; status: completed.
02
Drugs
hydralazinevalproic acid
03
Conditions
narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on NL-OMON54746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54746.